-
4
-
-
0019998174
-
Phase II trial of vinblastine sulfate for metastatic urothelial tract tumors
-
Blumenreich M.S. Yagoda A. Natale R.B. Watson R.C. Phase II trial of vinblastine sulfate for metastatic urothelial tract tumors Cancer 50 1982 435
-
(1982)
Cancer
, vol.50
, pp. 435
-
-
Blumenreich, M.S.1
Yagoda, A.2
Natale, R.B.3
Watson, R.C.4
-
5
-
-
0020572413
-
Phase II trial of sequentially administered cisplatin, cyclophosphamide and doxorubicin for urothelial tract tumors
-
Schwartz S. Yagoda A. Natale R.B. Watson R.C. Whitmore W.F. Lesser M. Phase II trial of sequentially administered cisplatin, cyclophosphamide and doxorubicin for urothelial tract tumors J. Urol. 130 1983 681
-
(1983)
J. Urol.
, vol.130
, pp. 681
-
-
Schwartz, S.1
Yagoda, A.2
Natale, R.B.3
Watson, R.C.4
Whitmore, W.F.5
Lesser, M.6
-
6
-
-
0020703153
-
Chemotherapy for advanced urothelial cancer
-
Yagoda A. Chemotherapy for advanced urothelial cancer Sem. Urol. 1 1983 60
-
(1983)
Sem. Urol.
, vol.1
, pp. 60
-
-
Yagoda, A.1
-
7
-
-
85113019324
-
-
Ahmed, T., Yagoda, A., Needles, B., Scher, H. I., Watson, R. C. and Geller, N.: Vinblastine and methotrexate for advanced bladder cancer. J. Urol., in press.
-
-
-
-
8
-
-
0018840731
-
Chemotherapy of metastatic bladder cancer
-
Yagoda A. Chemotherapy of metastatic bladder cancer Cancer 45 1980 1879
-
(1980)
Cancer
, vol.45
, pp. 1879
-
-
Yagoda, A.1
-
9
-
-
0018637134
-
Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia
-
Chello P.L. Sirotnak F.M. Dorick D.M. Moccio D.M. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia Cancer Treat. Rep. 63 1979 1889
-
(1979)
Cancer Treat. Rep.
, vol.63
, pp. 1889
-
-
Chello, P.L.1
Sirotnak, F.M.2
Dorick, D.M.3
Moccio, D.M.4
-
10
-
-
84912706313
-
Improved activity and toxicity of cyclophosphamide (CTX), adriamycin (ADR) and cis-diamminedichloroplatinum (DDP), combination (CAD) as compared to DDP in disseminated transitional cell carcinomas of the urinary tract (DTCUT)
-
Khandekar J.D. Elson P.J. DeWys W.D. Improved activity and toxicity of cyclophosphamide (CTX), adriamycin (ADR) and cis-diamminedichloroplatinum (DDP), combination (CAD) as compared to DDP in disseminated transitional cell carcinomas of the urinary tract (DTCUT) Proc. Amer. Soc. Clin Oncol. 2 1983 143 abstract C-560
-
(1983)
Proc. Amer. Soc. Clin Oncol.
, vol.2
, pp. 143
-
-
Khandekar, J.D.1
Elson, P.J.2
DeWys, W.D.3
-
11
-
-
0020961967
-
Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group Study. Amer
-
Gagliano R. Levin H. El-Bolkainy M.N. Wilson H.E. Stephens R.L. Fletcher W.S. Rivkin S.E. O’Bryan R.M. Coltman C.A. Jr. Saiki J.H. Stuckey W.J. Balducci L. Bonnet J.D. Dixon D.O. Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group Study. Amer J. Clin Oncol. 6 1983 215
-
(1983)
J. Clin Oncol.
, vol.6
, pp. 215
-
-
Gagliano, R.1
Levin, H.2
El-Bolkainy, M.N.3
Wilson, H.E.4
Stephens, R.L.5
Fletcher, W.S.6
Rivkin, S.E.7
O’Bryan, R.M.8
Coltman, C.A.9
Saiki, J.H.10
Stuckey, W.J.11
Balducci, L.12
Bonnet, J.D.13
Dixon, D.O.14
-
12
-
-
84912656416
-
Cisplatin, methotrexate, and vinblastine (CMV) chemotherapy (CT) for metastatic cancer of the uroepithelium
-
Harker W.G. Freiha F.S. Shortliffe L.D. Meyers F.J. Hannigan J.F. Jr. Flam M.S. Torti F.M. Cisplatin, methotrexate, and vinblastine (CMV) chemotherapy (CT) for metastatic cancer of the uroepithelium Proc. Amer. Soc. Clin Oncol. 2 1983 135 abstract C-530
-
(1983)
Proc. Amer. Soc. Clin Oncol.
, vol.2
, pp. 135
-
-
Harker, W.G.1
Freiha, F.S.2
Shortliffe, L.D.3
Meyers, F.J.4
Hannigan, J.F.5
Flam, M.S.6
Torti, F.M.7
-
13
-
-
0021366049
-
Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma
-
Oliver R.T.D. England H.R. Risdon R.A. Blandy J.P. Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma J. Urol. 131 1984 483
-
(1984)
J. Urol.
, vol.131
, pp. 483
-
-
Oliver, R.T.D.1
England, H.R.2
Risdon, R.A.3
Blandy, J.P.4
-
14
-
-
85005082193
-
Cisplatin + dichloromethotrexate (DCM): a pharmacologically rational combination with high activity
-
Natale R.B. Wheeler R.H. Ensminger W. Miller D. Cisplatin + dichloromethotrexate (DCM): a pharmacologically rational combination with high activity Proc. Amer. Ass. Cancer Res. 24 1983 166 abstract 659
-
(1983)
Proc. Amer. Ass. Cancer Res.
, vol.24
, pp. 166
-
-
Natale, R.B.1
Wheeler, R.H.2
Ensminger, W.3
Miller, D.4
-
15
-
-
0020691292
-
A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract
-
Citrin D.L. Hogan T.F. Davis T.E. A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract Cancer 51 1983 1
-
(1983)
Cancer
, vol.51
, pp. 1
-
-
Citrin, D.L.1
Hogan, T.F.2
Davis, T.E.3
-
16
-
-
0020656087
-
Chemotherapy for metastatic transitional carcinoma of the urinary tract. A prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis-platinum for failure
-
Tannock I.F. Gospodarowicz M. Evans W.K. Chemotherapy for metastatic transitional carcinoma of the urinary tract. A prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis-platinum for failure Cancer 51 1983 216
-
(1983)
Cancer
, vol.51
, pp. 216
-
-
Tannock, I.F.1
Gospodarowicz, M.2
Evans, W.K.3
|